These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6454571)

  • 1. Elevated serum DHEA-S levels in association with hyperprolactinemia.
    Seki K; Kato K
    Endocrinol Jpn; 1981 Feb; 28(1):79-81. PubMed ID: 6454571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin modulation of dehydroepiandrosterone sulfate secretion.
    Lobo RA; Kletzky OA; Kaptein EM; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):632-6. PubMed ID: 6449151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased androgen secretion in patients with prolactinomas: the impact of altered HPA function.
    Moria Y; Kortbawi R; El-Asmar N; Arafah BM
    Pituitary; 2019 Apr; 22(2):170-178. PubMed ID: 30798438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
    Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
    J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hyperprolactinemia on the diurnal variation of adrenal androgens.
    Clapp DH; Wiebe RH
    Fertil Steril; 1983 Jun; 39(6):749-52. PubMed ID: 6221947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin has a direct effect on adrenal androgen secretion.
    Higuchi K; Nawata H; Maki T; Higashizima M; Kato K; Ibayashi H
    J Clin Endocrinol Metab; 1984 Oct; 59(4):714-8. PubMed ID: 6090494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
    Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
    Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
    J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dehydroepiandrosterone-sulphate (DHEA-S) administration on puerperal lactation and maternal prolactin and estradiol levels.
    Aisaka K; Mori H; Ogawa T; Kigawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1935-42. PubMed ID: 6238998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women.
    Steinberger E; Smith KD; Rodriguez-Rigau LJ
    J Clin Endocrinol Metab; 1984 Sep; 59(3):471-7. PubMed ID: 6235239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of acute changes in prolactin to affect DHEA-S secretion in the human.
    Wiebe RH; Handwerger S
    J Reprod Med; 1983 Mar; 28(3):206-8. PubMed ID: 6222183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
    Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum dehydroepiandrosterone sulfate and the use of clomiphene citrate in anovulatory women.
    Hoffman D; Lobo RA
    Fertil Steril; 1985 Feb; 43(2):196-9. PubMed ID: 3155698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
    Seki K; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):721-5. PubMed ID: 3830074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women.
    Hoffman DI; Klove K; Lobo RA
    Fertil Steril; 1984 Jul; 42(1):76-81. PubMed ID: 6327404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency.
    Yamaji T; Ishibashi M; Takaku F; Itabashi A; Katayama S; Ishii J
    J Clin Endocrinol Metab; 1987 Sep; 65(3):448-51. PubMed ID: 2957384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of hyperprolactinemia in 70 women with amenorrhea.
    Potashnik G; Bar-Ziv J; Glick S; Shoham A; Ben-Aderet N
    Isr J Med Sci; 1978 Jul; 14(7):753-61. PubMed ID: 681167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.